Posaconazole: Difference between revisions

From IDWiki
No edit summary
()
Line 1: Line 1:
== Therapeutic Drug Monitoring ==
+
==Therapeutic Drug Monitoring==
* Measure trough 7 days after starting or adjusting dose, or adjusting interacting medications, or concerns of poor adherence or absorption
 
* For prophylaxis, target trough >0.7 mg/L, or random level 0.35 mg/L 48 h after starting therapy
 
* For treatment, target trough >1 mg/L
 
   
 
*Measure trough 7 days after starting or adjusting dose, or adjusting interacting medications, or concerns of poor adherence or absorption
 
*For prophylaxis, target trough >0.7 mg/L, or random level 0.35 mg/L 48 h after starting therapy
 
*For treatment, target trough >1 mg/L
  +
  +
=== Epidemiologic Cutoff Values ===
  +
{| class="wikitable"
  +
!Species
  +
!ECV (mcg/mL)
  +
|-
  +
|C. albicans
  +
|0.06
  +
|-
  +
|C. glabrata
  +
|2
  +
|-
  +
|C. parapsilosis
  +
|0.25
  +
|-
  +
|C. tropicalis
  +
|0.12
  +
|-
  +
|C. krusei
  +
|0.5
  +
|-
  +
|C. lusitaniae
  +
|0.12
  +
|-
  +
|C. guilliermondii
  +
|0.5
  +
|-
  +
|C. kefyr
  +
|0.25
  +
|}
 
[[Category:Triazoles]]
 
[[Category:Triazoles]]

Revision as of 12:00, 19 January 2021

Therapeutic Drug Monitoring

  • Measure trough 7 days after starting or adjusting dose, or adjusting interacting medications, or concerns of poor adherence or absorption
  • For prophylaxis, target trough >0.7 mg/L, or random level 0.35 mg/L 48 h after starting therapy
  • For treatment, target trough >1 mg/L

Epidemiologic Cutoff Values

Species ECV (mcg/mL)
C. albicans 0.06
C. glabrata 2
C. parapsilosis 0.25
C. tropicalis 0.12
C. krusei 0.5
C. lusitaniae 0.12
C. guilliermondii 0.5
C. kefyr 0.25